Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | P4HB | P07237 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11291636 | 0.98 | ELANE (0.46) | KMT2AESR1ESR2MEN1ELANE | |
| SCHEMBL688964 | 0.83 | KMT2A (0.48) | KMT2AESR1ESR2MEN1ELANE | |
| SCHEMBL688963 | 0.83 | KMT2A (0.48) | KMT2AESR1ESR2MEN1ELANE | |
| SCHEMBL689685 | 0.83 | KMT2A (0.48) | KMT2AESR1ESR2MEN1ELANE | |
| SCHEMBL140760 | 0.79 | THRB (0.56) | KMT2AESR1ESR2MEN1ELANE | |
| SCHEMBL6741501 | 0.79 | CYP11B1 (0.47) | KMT2AMEN1ELANEMAPTHTT | |
| SCHEMBL3976540 | 0.79 | KMT2A (0.50) | KMT2AMEN1GAAKDM4ECA1 | |
| SCHEMBL2129488 | 0.79 | LMNA (0.61) | KMT2AMEN1GAATDP1HTT | |
| SCHEMBL28744273 | 0.79 | LDHA (0.45) | KMT2AMEN1MAPTCA1CA2 | |
| SCHEMBL7523578 | 0.79 | MEN1 (0.50) | KMT2AESR1ESR2MEN1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0315786-A1 | Process for the preparation of a d-alfa-amino acid from the corresponding alfa-keto acid | STAMICARBON B.V. (NL) | 1989-05-17 | — | — | EP | claimed |
| CN-115851645-A | Proteobacterium vulgaris meso-diaminopimelate dehydrogenase mutant and application thereof | 江南大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-115702223-A | Phenolic resin and coating composition using the same | PPG工业俄亥俄公司 | 2023-02-14 | — | — | CN | disclosed |
| WO-2019135987-A1 | POLYCARBONATE DIOL COATING COMPOSITION FOR CAUSTIC AND UV RESISTANCE | FERRO CORPORATION (US) | 2019-07-11 | — | — | WO | disclosed |
| US-20190202733-A1 | Polycarbonate Diol Coating Composition For Caustic And UV Resistance | CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT | 2019-07-04 | — | — | US | disclosed |
| CN-104093831-A | Mbth-like proteins in the production of semi synthetic antibiotics | DSM SINOCHEM PHARM NL BV | 2014-10-08 | — | — | CN | disclosed |
| CN-101631853-B | Production of beta-lactam antibiotics | DSM IP ASSETS BV | 2013-04-24 | — | — | CN | disclosed |
| CN-1040541-C | Polypeptide compound and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-11-04 | — | — | CN | disclosed |
| WO-1997000678-A1 | METHODS RELATED TO THE TREATMENT OF AND ISOLATION OF COMPOUNDS FOR TREATMENT OF ISCHAEMIC CONDITIONS | THE QUEEN ELIZABETH HOSPITAL (AU) | 1997-01-09 | — | — | WO | disclosed |
| EP-0385053-B1 | Method for production of linoleum | MONDO SPA (IT) | 1994-07-27 | — | — | EP | disclosed |
| CN-1059729-A | Novel polypeptide compound and preparation method thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1992-03-25 | — | — | CN | disclosed |
| EP-0385053-A2 | Method for production of linoleum | MONDO S.p.A. (IT) | 1990-09-05 | — | — | EP | disclosed |
| EP-0315786-A1 | Process for the preparation of a d-alfa-amino acid from the corresponding alfa-keto acid | STAMICARBON B.V. (NL) | 1989-05-17 | — | — | EP | disclosed |
| US-4699727-A | POLYOXYALKYLENE POLYETHERS INITIATED WITH BISPHENOLS; NONSMOKING, ANTISLUDGING | BASF CORPORATION (US) | 1987-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202733-A1 | Polycarbonate Diol Coating Composition For Caustic And UV Resistance | DHCR24, ADH1C, ACMSD | KMT2A 2369/4885ESR1 3667/4885ESR2 3324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.